Latest news with #AgilentTechnologiesInc.
Yahoo
6 days ago
- Business
- Yahoo
[Latest] Global CRISPR Gene Editing Market Size/Share Worth USD 12.6 Billion by 2034 at a 13.01% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global CRISPR Gene Editing Market size & share revenue was valued at approximately USD 3.65 Billion in 2024 and is expected to reach USD 4.10 Billion in 2025 and is expected to reach around USD 12.6 Billion by 2034, at a CAGR of 13.01% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are CRISPR Therapeutics AG, Agilent Technologies Inc., Thermo Fisher Scientific Inc., GeneCopoeia Inc., Synthego Corporation, System Biosciences LLC, ToolGen Inc., Rockland Immunochemicals Inc., Horizon Discovery Group PLC, Abcam Inc., Applied StemCell Inc., Cellecta Inc and others. Austin, TX, USA, July 25, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled 'CRISPR Gene Editing Market Size, Trends and Insights By Product (Kits and Reagents, Services), By Gene Editing Modality (Ex-Vivo Editing, In-Vivo Editing), By Technology (CRISPR/Cas9 Technology, CRISPR/Cas12 Technology, Prime Editing, Epigenetic Editing, Others), By Application (Therapeutic Applications, Agriculture and Livestock, Industrial Biotechnology), By End User (Biotechnology and Pharmaceutical Companies, Agricultural and Livestock Industry, Hospitals and Clinics, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034' in its research database. 'According to the latest research study, the demand of the global CRISPR Gene Editing Market size & share was valued at approximately USD 3.65 Billion in 2024 and is expected to reach USD 4.10 Billion in 2025 and is expected to reach a value of around USD 12.6 Billion by 2034, at a compound annual growth rate (CAGR) of about 13.01% during the forecast period 2025 to 2034.' Click Here to Access a Free Sample Report of the Global CRISPR Gene Editing Market @ Overview As per the industry experts at CMI, Major players in the CRISPR gene editing segment such as CRISPR Therapeutics AG, Agilent Technologies Inc., Thermo Fisher Scientific Inc., and GeneCopoeia Inc., are enhancing precision gene editing via scalable platforms and solutions from synthetic biology. With the automation and genomic cloud computing these companies intend to enhance CRISPR's precision and efficacy, they will utilize AI-generated guide RNAs. Other active ventures focus on plant and agricultural biopharmaceuticals, therapeutic biopharmaceuticals, or functional genomics. Collaborations between universities, clinics, and the biotech sector are on the rise, which accelerates innovation and globalization. Compliance with FDA, EMA, ISO, ESG, and CSR requirements strengthens green laboratory sustainability initiatives. These enduring strategic focuses enable still transformative advances in CRISPR. Key Trends & Drivers The Rise in Demand for Personalized Medicine: This is the increasing need for treatments based on and tailored to an individual's genetic composition. This increases efficiency and reduces adverse drug reactions. CRISPR technology aids in this by enabling on-target, specific edits. In March 2025, a CRISPR-based therapy received expanded orphan drug designation from the FDA for treating a rare genetic liver metabolic disorder which marked a regulatory milestone. Furthermore, pharmaceutical manufacturers have several personalized CRISPR clinical programs in progress for sickle cell and retinal diseases. These initiatives highlight the increasing momentum and investment behind tailored patient-specific, gene-editing therapies. As trials expand, the clinical availability of tailored CRISPR therapies approaches reality. Growth in Agricultural Biotechnology: This concerns the application of CRISPR technology for modification of essential traits in crops like yield, climate resilience and pest resistance to solve food crises around the world. There is relaxed concern with GMO crops as emerging markets are granting less red tape than traditional GMOs to genome edited crops. In late 2024, a multinational agri-biotech consortium conducted successful pilot trials of drought resistant CRISPR maize in sub-saharan Africa. Since then, major seed companies have formed alliances aimed at bringing these next generation crops to market. The surge in the funding of agricultural startups specializing in gene editing technologies reached nearly double the amount received throughout 2024 in the first quarter of 2025. This strongly substantiates the impact and promise of CRISPR on sustainable agriculture. Request a Customized Copy of the CRISPR Gene Editing Market Report @ The Integration of Synthetic Biology: The rise of synthetic biology is a relatively more recent phenomenon within the life sciences. Synthetic biology is the infusion of CRISPR genetic modification into frameworks designated for creating biomaterials, therapeutics, and diagnostics. It promotes creativity by programming biological functions into living organisms. In January 2025, one of the leaders in the industry launched a fully automated CRISPR workstation that designs host organisms for enzyme production. In the same quarter, CRISPR editing kits meant for easier construction of sophisticated metabolic pathways were issued. These tools which permit rapid prototyping and bioproduction, are alleviating constraints in biomanufacturing. The remarkable progress made in synthetic biology is motivating the greater adoption of CRISPR technologies by the industrial and academic sectors. Report Scope Feature of the Report Details Market Size in 2025 USD 4.10 Billion Projected Market Size in 2034 USD 12.6 Billion Market Size in 2024 USD 3.65 Billion CAGR Growth Rate 13.01% CAGR Base Year 2024 Forecast Period 2025-2034 Key Segment By Product, Gene Editing Modality, Technology, Application, End User and Region Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America Buying Options Request tailored purchasing options to fulfil your requirements for research. (A free sample of the CRISPR Gene Editing report is available upon request; please contact us for more information.) Our Free Sample Report Consists of the following: Introduction, Overview, and in-depth industry analysis are all included in the 2024 updated report. The COVID-19 Pandemic Outbreak Impact Analysis is included in the package. About 220+ Pages Research Report (Including Recent Research) Provide detailed chapter-by-chapter guidance on the Request. Updated Regional Analysis with a Graphical Representation of Size, Share, and Trends for the Year 2025 Includes Tables and figures have been updated. The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis Custom Market Insights (CMI) research methodology (Please note that the sample of the CRISPR Gene Editing report has been modified to include the COVID-19 impact study prior to delivery.) Request a Customized Copy of the CRISPR Gene Editing Market Report @ SWOT Analysis Strengths: The applicability of CRISPR technology spans over various domains, from healthcare and agriculture to diagnostics, making it easier to adopt and innovate. Unlike traditional gene editing methodologies, it is much more cost efficient, precise, and effective. Further, it undergoes fewer regulatory roadblocks. Strong competitors, coupled with increased research and development spending and greater regulatory acceptance for clinical trial approvals, also serve to propel the industry. Lastly, the core principles of the technology's design foster worldwide ingenuity, industrial adoption, and innovation. Weaknesses: Concerns from other sectors such as off target effects and ineffective delivery mechanisms pose significant ethical barriers that conflict with the acceptance of CRISPR technology. Furthermore, lack of global uniform regulations creates disputes of ownership which stifles the key players in the industry. From a public standpoint, these issues damage perception of trust and the ability to scale commercially. There are also broader societal barriers, including the overly complex therapeutic development process and high reliability costs that work counter to public adoption. Opportunities: Increased interactions between government and private organizations coupled with the advances in synthetic biology create purpose built medicine and fuel emerging markets. Focused agricultural innovations also enable wide scale adoption in developing nations. With innovations like prime editing and base editing, emerging technologies bring vast commercial prospects. Moreover, automation alongside AI powered guide RNA creates the opportunity for high precision design. Threats: Unresolved controversies, including regulatory uncertainty, ethical concerns (particularly relating to germline editing), and biosafety issues, remain looming threats. Market share might be affected by competition from TALEN and ZFN as other alternative technologies for genome editing. Clinical progress may be hampered by legal restrictions or public backlash. In addition, latent cybersecurity risks in digital genomics and the misuse of data continue to be troubling matters. Request a Customized Copy of the CRISPR Gene Editing Market Report @ Key questions answered in this report: What is the size of the CRISPR Gene Editing market and what is its expected growth rate? What are the primary driving factors that push the CRISPR Gene Editing market forward? What are the CRISPR Gene Editing Industry's top companies? What are the different categories that the CRISPR Gene Editing Market caters to? What will be the fastest-growing segment or region? In the value chain, what role do essential players play? What is the procedure for getting a free copy of the CRISPR Gene Editing market sample report and company profiles? Key Offerings: Market Share, Size & Forecast by Revenue | 2025−2034 Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Leading Trends Market Segmentation – A detailed analysis by Types of Services, by End-User Services, and by regions Competitive Landscape – Top Key Vendors and Other Prominent Vendors Buy this Premium CRISPR Gene Editing Research Report | Fast Delivery Available - [220+ Pages] @ Regional Perspective The CRISPR Gene Editing Market can be divided across different regions such as North America, Europe, Asia-Pacific, and LAMEA. This is a cursory overview of each region: North America: Structured CRISPR research in the biotech sector of the United States, Canada, and Mexico makes a marked difference to CRISPR innovation as a whole. With global leaders in reagents as well as in Synthetic Biology, the region provides tremendous public and private funding in advanced biotech companies. With the new gene-editing firm opening its CRISPR facility in Massachusetts in February 2024, we are expecting sharp growth in North America Made Cas enzyme production. This confirms what we already knew regarding North America's advancements in commercial and clinical CRISPR usage. Europe: Countries like Germany, France, the UK, and Spain are jumping headfirst into commercial uses of CRISPR technology. With powerful sectors and public relations controlling the narrative, biosafety, ethics, and public engagement receive more than enough focus. The clinical trial commenced in Germany, with the France and Netherlands branches later allowing cross-border integration, which showcases the strength of collaborative effort when harnessed for rare blood disorder therapies. Asia Pacific: The Asia-Pacific region hosts state-of-the-art innovation centers like China, Japan, India, South Korea, New Zealand, Australia, Taiwan, and others. They are aggressively adopting CRISPR Technology in agriculture, healthcare, and bioengineering. This region is also scaling up the clinical applications and their associated governance structures. In August 2025, China achieved a significant milestone in regional self-sufficiency by deploying the first in-house CRISPR Cas12-based infectious disease screening systems. This rollout shows the increasing potential of implementing gene-editing technology at scale in Asia-Pacific. LAMEA: Other regions such as Brazil, the Middle East, and Africa fall under the LAMEA classification. These areas are beginning to adopt CRISPR technology in agriculture, public health initiatives, and even in developing organizational capacity. There is positive momentum in investment levels and regulatory sophistication. In October 2024 Brazil launched national field trials of CRISPR-edited drought resistant maize varieties, becoming the first country to have a government-backed genome editing crop initiative. Under this project, LAMEA countries are bolstering their commitment to food security and sustainable development while aiming to significantly enhance agricultural productivity. Request a Customized Copy of the CRISPR Gene Editing Market Report @ (We customized your report to meet your specific research requirements. Inquire with our sales team about customizing your report.) Still, Looking for More Information? Do OR Want Data for Inclusion in magazines, case studies, research papers, or Media? Email Directly Here with Detail Information: support@ Browse the full 'CRISPR Gene Editing Market Size, Trends and Insights By Product (Kits and Reagents, Services), By Gene Editing Modality (Ex-Vivo Editing, In-Vivo Editing), By Technology (CRISPR/Cas9 Technology, CRISPR/Cas12 Technology, Prime Editing, Epigenetic Editing, Others), By Application (Therapeutic Applications, Agriculture and Livestock, Industrial Biotechnology), By End User (Biotechnology and Pharmaceutical Companies, Agricultural and Livestock Industry, Hospitals and Clinics, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034' Report at List of the prominent players in the CRISPR Gene Editing Market: CRISPR Therapeutics AG Agilent Technologies Inc. Thermo Fisher Scientific Inc. GeneCopoeia Inc. Synthego Corporation System Biosciences LLC ToolGen Inc. Rockland Immunochemicals Inc. Horizon Discovery Group PLC Abcam Inc. Applied StemCell Inc. Cellecta Inc Others Click Here to Access a Free Sample Report of the Global CRISPR Gene Editing Market @ Spectacular Deals Comprehensive coverage Maximum number of market tables and figures The subscription-based option is offered. Best price guarantee Free 35% or 60 hours of customization. Free post-sale service assistance. 25% discount on your next purchase. Service guarantees are available. Personalized market brief by author. Browse More Related Reports: CRISPR and Cas Genes Market: CRISPR and Cas Genes Market Size, Trends and Insights By Technology Type (CRISPR/Cas9, CRISPR/Cas13, CRISPR/Cas14, Others), By Delivery Method (Ex vivo, In vivo, Physical Methods, Others), By Application Area (Functional Genomics, Oncology, Infectious Diseases, Others), By Tool Type (Guide RNA, CRISPR Plasmids, Cas Nucleases, Custom CRISPR Libraries, Vectors & Cloning Kits), By Crop Type (Cereals & Grains, Fruits & Vegetables, Oilseeds & Pulses, Industrial Crops), By Disease Type (Cancer, Blood Disorders, Ophthalmic Diseases, Infectious Diseases, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 Japan Tissue Engineering Market: Japan Tissue Engineering Market Size, Trends and Insights By Type (Synthetic Scaffold Material, Biologically Derived Scaffold Material, Others), By Application (Orthopedics and Musculoskeletal, Neurology, Cardiovascular, Skin and Integumentary, Dental, Others), By End user (Hospitals and Clinics, Ambulatory Facilities), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 North America Oral Care Market: North America Oral Care Market Size, Trends and Insights By Product Type (Toothbrush, Manual, Electric (Rechargeable), Battery-powered (Non-rechargeable), Others, Toothpaste, Gel, Polish, Paste, Powder, Mouthwash/Rinse, Medicated, Non-medicated, Denture Products, Cleaners, Fixatives, Floss, Others, Dental Accessories, Cosmetic Whitening Products, Fresh Breath Dental Chewing Gum, Tongue Scrapers, Fresh Breath Strips, Others, Oral Irrigators, Mouth Freshener Sprays), By Age Group (Kids, Adults, Geriatric), By Type (Countertop, Cordless), By Application (Home, Dentistry), By Sales Channel (Hypermarkets/Supermarkets, Specialty Stores, Drug Stores &Pharmacies, Convenience Stores, Online Sales Channel), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 Japan Cell Cancer Vaccine Market: Japan Cell Cancer Vaccine Market Size, Trends and Insights By Vaccine Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines, Oncolytic Viruses), By Indication (Prostate Cancer, Cervical Cancer), By Technology (Peptide-based Vaccines, Vector-based Vaccines, DNA/RNA-based Vaccines), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 mRNA Cancer Vaccine Market: mRNA Cancer Vaccine Market Size, Trends and Insights By Cancer Type (Melanoma, Lung Cancer (NSCLC), Prostate Cancer, Pancreatic Cancer, Colorectal Cancer), By Application/Use Case (Therapeutic Cancer Vaccines, Preventive/Prophylactic Cancer Vaccines), By Delivery Mechanism (Lipid Nanoparticles (LNPs), Polymer-Based Carriers, Electroporation), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 Neoantigen Cancer Vaccine Market: Neoantigen Cancer Vaccine Market Size, Trends and Insights By Product (Personalised antigen vaccine, Off-the-shelf neoantigen vaccine), By Neoantigen Type (Synthetic Long Peptide, Nucleic acid, Dendritic cell, Tumour cell), By Route of Administration (Intravenous, Intramuscular, Transdermal), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 US Pharmaceutical Drug Delivery Market: US Pharmaceutical Drug Delivery Market Size, Trends and Insights By Route of Administration (Oral, Ocular, Pulmonary, Nasal, Injectable, Topical, Other), By Application (Cardiovascular Diseases, Diabetes, Cancer, Infectious Diseases, Others), By End-user (Hospitals, Ambulatory Services, Home Healthcare), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 Peptide Cancer Vaccine Market: Peptide Cancer Vaccine Market Size, Trends and Insights By Type (Multivalent Peptide Vaccine, Peptide Cocktail Type, Personalized Peptide Vaccine, Peptide-Pulsed Dendritic Cancer Vaccine, Hybrid Peptide Vaccine), By Application (Breast Cancer, Lung Cancer, Melanoma, Prostate Cancer), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 The CRISPR Gene Editing Market is segmented as follows: By Product Kits and Reagents Services By Gene Editing Modality Ex-Vivo Editing In-Vivo Editing By Technology CRISPR/Cas9 Technology CRISPR/Cas12 Technology Prime Editing Epigenetic Editing Others By Application Therapeutic Applications Agriculture and Livestock Industrial Biotechnology By End User Biotechnology and Pharmaceutical Companies Agricultural and Livestock Industry Hospitals and Clinics Others Click Here to Get a Free Sample Report of the Global CRISPR Gene Editing Market @ Regional Coverage: North America U.S. Canada Mexico Rest of North America Europe Germany France U.K. Russia Italy Spain Netherlands Rest of Europe Asia Pacific China Japan India New Zealand Australia South Korea Taiwan Rest of Asia Pacific The Middle East & Africa Saudi Arabia UAE Egypt Kuwait South Africa Rest of the Middle East & Africa Latin America Brazil Argentina Rest of Latin America This CRISPR Gene Editing Market Research/Analysis Report Contains Answers to the following Questions. Which Trends Are Causing These Developments? Who Are the Global Key Players in This CRISPR Gene Editing Market? What are Their Company Profile, Product Information, and Contact Information? What Was the Global Market Status of the CRISPR Gene Editing Market? What Was the Capacity, Production Value, Cost and PROFIT of the CRISPR Gene Editing Market? What Is the Current Market Status of the CRISPR Gene Editing Industry? What's Market Competition in This Industry, Both Company and Country Wise? What's Market Analysis of CRISPR Gene Editing Market by Considering Applications and Types? What Are Projections of the Global CRISPR Gene Editing Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about imports and exports? What Is CRISPR Gene Editing Market Chain Analysis by Upstream Raw Materials and Downstream Industry? What Is the Economic Impact On CRISPR Gene Editing Industry? What are Global Macroeconomic Environment Analysis Results? What Are Global Macroeconomic Environment Development Trends? What Are Market Dynamics of CRISPR Gene Editing Market? What Are Challenges and Opportunities? What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for CRISPR Gene Editing Industry? Click Here to Access a Free Sample Report of the Global CRISPR Gene Editing Market @ Reasons to Purchase CRISPR Gene Editing Market Report CRISPR Gene Editing Market Report provides qualitative and quantitative analysis of the market based on segmentation involving economic and non-economic factors. CRISPR Gene Editing Market report outlines market value (USD) data for each segment and sub-segment. This report indicates the region and segment expected to witness the fastest growth and dominate the market. CRISPR Gene Editing Market Analysis by geography highlights the consumption of the product/service in the region and indicates the factors affecting the market within each region. The competitive landscape incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled. Extensive company profiles comprising company overview, company insights, product benchmarking, and SWOT analysis for the major market players. The Industry's current and future market outlook concerning recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging and developed regions. CRISPR Gene Editing Market Includes in-depth market analysis from various perspectives through Porter's five forces analysis and provides insight into the market through Value Chain. Reasons for the Research Report The study provides a thorough overview of the global CRISPR Gene Editing market. Compare your performance to that of the market as a whole. Aim to maintain competitiveness while innovations from established key players fuel market growth. Buy this Premium CRISPR Gene Editing Research Report | Fast Delivery Available - [220+ Pages] @ What does the report include? Drivers, restrictions, and opportunities are among the qualitative elements covered in the worldwide CRISPR Gene Editing market analysis. The competitive environment of current and potential participants in the CRISPR Gene Editing market is covered in the report, as well as those companies' strategic product development ambitions. According to the component, application, and industry vertical, this study analyzes the market qualitatively and quantitatively. Additionally, the report offers comparable data for the important regions. For each segment mentioned above, actual market sizes and forecasts have been given. Who should buy this report? Participants and stakeholders worldwide CRISPR Gene Editing market should find this report useful. The research will be useful to all market participants in the CRISPR Gene Editing industry. Managers in the CRISPR Gene Editing sector are interested in publishing up-to-date and projected data about the worldwide CRISPR Gene Editing market. Governmental agencies, regulatory bodies, decision-makers, and organizations want to invest in CRISPR Gene Editing products' market trends. Market insights are sought for by analysts, researchers, educators, strategy managers, and government organizations to develop plans. Request a Customized Copy of the CRISPR Gene Editing Market Report @ About Custom Market Insights: Custom Market Insights is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies and regularly work towards achieving sustainable growth in their respective domains. CMI provides a one-stop solution for data collection to investment advice. The expert analysis of our company digs out essential factors that help to understand the significance and impact of market dynamics. The professional experts apply clients inside on the aspects such as strategies for future estimation, forecasting or opportunity to grow, and consumer surveys. Follow Us: LinkedIn | Twitter | Facebook | YouTube Contact Us: Joel John CMI Consulting LLC 1333, 701 Tillery Street Unit 12, Austin, TX, Travis, US, 78702 USA: +1 737-734-2707 India: +91 20 46022736 Email: support@ Web: Blog: Blog: Blog: Blog: Buy this Premium CRISPR Gene Editing Research Report | Fast Delivery Available - [220+ Pages] @ in to access your portfolio
Yahoo
31-01-2025
- Business
- Yahoo
Genomics Market to Grow by USD 5.21 Billion (2024-2028), Boosted by Rising Investments in R&D, with AI Driving Market Transformation
NEW YORK, Jan. 30, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The global genomics market size is estimated to grow by USD 5.21 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 3.16% during the forecast period. Rising investments in genomics research and development is driving market growth, with a trend towards advances in sequencing technologies. However, varying regulations in genomics research and testing poses a challenge. Key market players include 10X Genomics Inc., Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., BGI Group, Bio Rad Laboratories Inc., Danaher Corp., Eppendorf SE, F. Hoffmann La Roche Ltd., Hamilton Bonaduz AG, Illumina Inc., Myriad Genetics Inc., New England Biolabs Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Promega Corp., QIAGEN NV, Standard BioTools Inc., Thermo Fisher Scientific Inc., and PerkinElmer Inc. Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View Free Sample PDF Genomics Market Scope Report Coverage Details Base year 2023 Historic period 2018 - 2022 Forecast period 2024-2028 Growth momentum & CAGR Accelerate at a CAGR of 3.16% Market growth 2024-2028 USD 5.21 billion Market structure Fragmented YoY growth 2022-2023 (%) 2.5 Regional analysis North America, Europe, Asia, and Rest of World (ROW) Performing market contribution North America at 33% Key countries US, UK, Germany, France, and China Key companies profiled 10X Genomics Inc., Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., BGI Group, Bio Rad Laboratories Inc., Danaher Corp., Eppendorf SE, F. Hoffmann La Roche Ltd., Hamilton Bonaduz AG, Illumina Inc., Myriad Genetics Inc., New England Biolabs Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Promega Corp., QIAGEN NV, Standard BioTools Inc., Thermo Fisher Scientific Inc., and PerkinElmer Inc Market Driver The global genomics market is experiencing significant growth, driven by trends in artificial intelligence (AI) and bioengineering. Companies like Complete Genomics, Illumina, and Singular Genomics Systems lead the way in next-generation sequencing (NGS), while Eurofins Scientific and PCR Biosystems focus on diagnostics. Cancer, chronic diseases, and rare disorder diagnosis are key applications. Ethical issues and trade regulations are important considerations. Bioengineering and synthetic biology are revolutionizing gene therapy and personalized medicine. Sensitive instruments, such as flow cytometry and microarrays, are essential tools. Janssen, Life Sciences Vision, Front Line Genomics, and Trivitron Healthcare are also significant players. Raw material suppliers and trained professionals are crucial for market expansion. Multi-omic-based approaches and the diagnosis of viral diseases are emerging trends. Geographic expansion and the integration of AI in genomics are future growth opportunities. The Human Genome Project (HGP) has played a pivotal role in advancing our understanding of the human genome structure. Next-generation genetic testing technologies, born from the HGP, offer vendors valuable tools for managing comprehensive human genome sets and deciphering genetic functions. These advancements have revolutionized medical research, enabling the detection of disease-causing mutations and gene variants. Additionally, next-generation sequencing (NGS) has significantly reduced the cost of genomics analysis and database management, making it more accessible and affordable for researchers worldwide. NGS technology has revolutionized the genomics market by facilitating large-scale sequencing and offering insights into genetic variations that contribute to various disorders. Request Sample of our comprehensive report now to stay ahead in the AI-driven market evolution! Market Challenges The global genomics market is experiencing significant growth due to advancements in technologies like Next-Generation Sequencing (NGS) and microarrays. Companies like Illumina, Complete Genomics, and Eurofins Scientific lead the market. Challenges include ethical issues, trade regulations, and the need for trained professionals. AI and bioengineering are driving innovation in gene therapy and synthetic biology. Cancer, chronic diseases, and rare disorder diagnoses are major applications. Key players are expanding geographically. Diagnostics, PCR Biosystems, Sensitive Instruments, Front Line Genomics, and Trivitron Healthcare provide solutions. Raw material suppliers and Life Sciences Vision are crucial partners. Multi-omic-based approaches and NGS are revolutionizing personalized medicine. Ethical issues and sensitivity to viral diseases are concerns. Janssen and Singular Genomics Systems are pioneering in cancer and gene therapy. Flow cytometry and bioengineering are essential for cancer research. Bioengineering and AI are crucial in cancer and chronic disease research. Cancer, chronic diseases, and genetic disorders are primary applications. Geographic expansion and regulatory compliance are key challenges. The global genomics market presents both opportunities and challenges for vendors due to varying regulatory standards and compliances. With products used in highly regulated applications like diagnostics, research, therapeutics, and drug discovery, vendors face stringent requirements for accuracy, quality, safety, and performance. Operating globally necessitates standardizing products to meet the regulatory requirements of authorities such as the US FDA, EMA, EAEMP, and ATGA. Ensuring compliance with these agencies' guidelines is crucial for market success. Discover how AI is revolutionizing market trends- Get your access now! Segment Overview This genomics market report extensively covers market segmentation by Solution 1.1 Products 1.2 Services Application 2.1 Diagnostic 2.2 Drug discovery 2.3 Precision medicine and others Geography 3.1 North America 3.2 Europe 3.3 Asia 3.4 Rest of World (ROW) 1.1 Products- The Genomics Market encompasses instruments and consumables utilized in genomics research and testing. Instruments include Polymerase chain reaction systems, CRISPR-Cas systems, next-generation sequencers, and microarray instruments, which perform nucleic acid extraction, isolation, purification, gene cloning/amplification, high-throughput sequencing, and gene expression. Vendors focus on advanced products with features like LIMS compatibility, automation, high throughput, and multiple read/run modes. Automation reduces hands-on time, minimizes errors, and ensures high accuracy. Automated systems, such as thermal cyclers, liquid handling systems, and sequencers, are increasingly adopted. Fully automated workflows, like library preparation workflows, are offered through partnerships. Automated instruments ease the workload in genomics labs but have high capital costs. Consumables include buffers, master mixes, kits, primers, probes, reagents, dyes, and chemicals. Advances in targeted sequencing, biomarker identification, and technologies like CRISPR Cas9, NGS, and LCMS fuel market growth. Vendors benefit from cost savings through NGS technology, which simplifies primer and probe production, and the use of LCMS for characterization and quantitation. CRISPR Cas9 offers customized genomic editing solutions. These factors will drive the Global Genomics Market's growth during the forecast period. Download a Sample of our comprehensive report today to discover how AI-driven innovations are reshaping competitive dynamics Research Analysis The Global Genomics Market is experiencing significant growth due to advancements in Artificial Intelligence (AI) and Bioengineering, leading to the development of innovative technologies such as Next-generation Sequencing (NGS) and Microarrays. These technologies are revolutionizing various industries, including Cancer research, Diagnostics, and Personalized Medicine, enabling the identification of genetic markers for Chronic diseases, Rare Disorder Diagnosis, and Viral diseases. Ethical issues surrounding the use of Genomic data and the need for Trained professionals to interpret complex data are key challenges. Geographic Expansion is a major trend, with companies like Eurofins Scientific, Illumina, and Trivitron Healthcare expanding their reach. Multi-omic-based approaches, Gene therapy, Synthetic biology, and Flow cytometry are also driving market growth. Companies like Complete Genomics, Front Line Genomics, Janssen, Life Sciences Vision, PCR Biosystems, Singular Genomics Systems, and others are at the forefront of these developments. The market is expected to continue growing as these technologies are applied to various applications, including Cancer treatment, Chronic disease management, and the diagnosis of Genetic disorders. Market Research Overview The Global Genomics Market is experiencing significant growth due to advancements in Artificial Intelligence (AI) and Bioengineering, leading to the development of innovative technologies like Next-Generation Sequencing (NGS) and Microarrays. These technologies are revolutionizing various sectors, including Cancer research, Diagnostics for Chronic diseases, and Rare Disorder Diagnosis. The market encompasses several areas such as Gene therapy, Synthetic biology, and Sensitive Instruments, providing solutions for Genetic disorders and Viral diseases. Geographic Expansion is a key trend, with companies investing in emerging markets to tap into untapped potential. Multi-omic-based approaches are gaining popularity, integrating data from different omics to provide a more comprehensive understanding of complex diseases. Ethical issues surrounding the use of Genomic data and Trade Regulations are areas of concern. Raw material suppliers, PCR Biosystems, and trained professionals play crucial roles in the value chain. Companies like Complete Genomics, Eurofins Scientific, Illumina, Janssen, Life Sciences Vision, Singular Genomics Systems, Trivitron Healthcare, and Front Line Genomics are leading the way in this dynamic industry. Flow cytometry and Science Council are also contributing significantly to the advancements in the field. Table of Contents: 1 Executive Summary2 Market Landscape3 Market Sizing4 Historic Market Size5 Five Forces Analysis6 Market Segmentation Solution Application Geography 7 Customer Landscape8 Geographic Landscape9 Drivers, Challenges, and Trends10 Company Landscape11 Company Analysis12 Appendix About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contacts Technavio ResearchJesse MaidaMedia & Marketing ExecutiveUS: +1 844 364 1100UK: +44 203 893 3200Email: media@ View original content to download multimedia: SOURCE Technavio Sign in to access your portfolio
